Allakos Inc.

NAS: ALLK

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

May 27, 2022, 8:40 a.m.

/zigman2/quotes/203639566/composite

$

2.70

Change

+0.04 +1.50%

Volume

Volume 2,509

Real time quotes

/zigman2/quotes/203639566/composite

Previous close

$ 2.66

$ 2.66

Change

+0.04 +1.53%

Day low

Day high

$2.59

$2.75

Open

52 week low

52 week high

$2.58

$112.87

Open

Steven P. James

Steven P. James is a businessperson who has been at the head of 5 different companies. He is Chairman of Antiva Biosciences, Inc., Executive Chairman, President & CEO at Pionyr Immunotherapeutics, Inc. and Chairman of Soteria Therapeutics, Inc. Steven P. James is also on the board of Allakos, Inc., Middlebridge School, Ventus Therapeutics, Inc. and Ventus Therapeutics U.S., Inc.

He previously occupied the position of Principal at Eli Lilly & Co., VP-Business Development & General Manager at Landec Corp., Vice President-Business Development of Ionis Pharmaceuticals, Inc., Senior Vice President-Commercial Operations at Exelixis, Inc., President & Chief Executive Officer of KAI Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Labrys Biologics, Inc., Chief Business Officer at Sunesis Pharmaceuticals, Inc. and Principal at California Biotechnology, Inc.

He received an undergraduate degree from Brown University and a graduate degree from Kellogg School of Management.

Transactions

Date Shares Transaction Value
09/28/2021 4,000   Disposition at $108.12 per share. 432,480
09/28/2021 4,000   Derivative/Non-derivative trans. at $0.52 per share. 2,080

Officers and Executives

Dr. Robert Alexander
Chief Executive Officer & Director
Dr. Adam L. Tomasi
President & Chief Operating Officer
Mr. Harlan Baird Radford
Chief Financial Officer
Dr. Ruby Casareno
Vice President-Technical Operations
Dr. Craig Paterson
Chief Medical Officer
Mr. Roland K. Winger
Senior Vice President
Mr. Meg Fitzgerald
Secretary, Chief Compliance Officer & Senior VP
Dr. Sally D. Bolmer
Vice President-Regulatory Affairs & Development
Mr. Alex Schwartz
Vice President-Investor Relations
Mr. Daniel S. Janney
Chairman
Dr. John P. McKearn
Independent Director
Mr. Steven P. James
Independent Director
Mr. Paul E. Walker
Independent Director
Mr. Robert E. Andreatta
Independent Director
Link to MarketWatch's Slice.